Table 3.
Maternal Cancer and Treatment Characteristics Among Women with Live Births Following a Cancer Diagnosis During Pregnancy
| Cancer and treatment characteristics | Women with live births following a cancer diagnosis during pregnancy N = 555 N (%) |
|---|---|
| Type of cancer | |
| Breast cancer | 184 (33) |
| Melanoma | 147 (26) |
| Thyroid cancer | 118 (21) |
| Lymphoma | 56 (10) |
| Gynecological cancera | 50 (9) |
| Stage of cancer at diagnosis | |
| In situ/Localizedb | 333 (60) |
| Regional | 181 (33) |
| Distant | 33 (6) |
| Chemotherapy | |
| No | 321 (59) |
| Yesc | 227 (41) |
| Chemotherapy initiated during pregnancy | 114 (50) |
| Chemotherapy initiated after pregnancy | 112 (50) |
| Surgery for gynecological cancer | 43 (86) |
| Underwent surgery during pregnancy | 25 (58) |
| Underwent surgery after pregnancy | 18 (42) |
| Radiation for gynecological cancer or lymphoma | |
| No | 85 (81) |
| Yes | 20 (19) |
| Radiation after delivery | 20 (100) |
a
Includes cervical, ovarian, and uterine cancer.
b
Includes 11 births to women with in situ breast cancer; all other births are to women with local invasive disease.
c
Includes subjects with missing information regarding timing of initiation of chemotherapy.